Intellia Therapeutics, Inc. (NTLA) Insider Trading

Name: Intellia Therapeutics, Inc. (NTLA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 24, 2026): LEONARD JOHN M (President and CEO): Sale of 19,890 shares, $250.6K.

Get alerted when insiders trade NTLA

Email address

Loading company data...

Beta

Loading company details...

Beta